Thornton v. Ipsen Biopharmaceuticals, Inc.

126 F.4th 76
CourtCourt of Appeals for the First Circuit
DecidedJanuary 16, 2025
Docket23-1951
StatusPublished
Cited by19 cases

This text of 126 F.4th 76 (Thornton v. Ipsen Biopharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Thornton v. Ipsen Biopharmaceuticals, Inc., 126 F.4th 76 (1st Cir. 2025).

Opinion

United States Court of Appeals For the First Circuit

No. 23-1951

REGINA M. THORNTON,

Plaintiff, Appellant,

v.

IPSEN BIOPHARMACEUTICALS, INC.,

Defendant, Appellee.

APPEAL FROM THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MASSACHUSETTS

[Hon. Jennifer C. Boal, U.S. Magistrate Judge]

Before

Barron, Chief Judge, Thompson and Gelpí, Circuit Judges.

Richard C. Chambers, Jr., with whom Joseph Spinale was on brief, for appellant.

Jonathan Rosenfeld and Michael Lenzi, with whom Wilmer Cutler Pickering Hale and Dorr LLP was on brief, for appellee.

January 16, 2025 GELPÍ, Circuit Judge. Plaintiff-Appellant Regina M.

Thornton ("Thornton") was employed by Defendant-Appellee Ipsen

Biopharmaceuticals, Inc. ("Ipsen") as Associate Director - Patient

Safety. In September 2021, Ipsen implemented a policy requiring

its employees to receive COVID-19 vaccinations. Citing her

religious beliefs, Thornton submitted a request for an exemption

from the vaccination requirement, which Ipsen denied. After

Thornton did not comply with the vaccination requirement, Ipsen

terminated her employment.

Thornton sued Ipsen in the Superior Court of

Massachusetts, County of Middlesex, alleging claims under Title

VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e-2(a) ("Title

VII"), and the corresponding Massachusetts law, Mass. Gen. Laws

ch. 151B ("Chapter 151B"); the Fourteenth Amendment to the United

States Constitution; and the Massachusetts Declaration of Rights

("MDR"). Ipsen removed the case to the United States District

Court for the District of Massachusetts and moved to dismiss all

counts. The United States Magistrate Judge who presided over the

case with the parties' consent granted Ipsen's motion, dismissing

Thornton's complaint. Thornton appealed.

For the reasons explained below, we reverse in part and

affirm in part.

- 2 - I. BACKGROUND

A. Factual Background

Because "this appeal follows the granting of a motion to

dismiss, we draw the relevant facts from the plaintiff's complaint"

and "from documentation incorporated by reference in the

complaint." Rivera–Díaz v. Humana Ins. of P.R., Inc., 748 F.3d

387, 388 (1st Cir. 2014) (citing Jorge v. Rumsfeld, 404 F.3d 556,

558-59 (1st Cir. 2005)). In reciting the facts, we accept as true

all well-pleaded allegations "and draw[] all reasonable inferences

in favor of the non-moving party." Squeri v. Mount Ida Coll., 954

F.3d 56, 61 (1st Cir. 2020) (citing Penate v. Hanchett, 944 F.3d

358, 362 (1st Cir. 2019)).

On September 7, 2021, Ipsen implemented a policy

requiring its employees to become "fully vaccinated" against

COVID-19 by November 1, 2021. Pursuant to the terms of the

vaccination policy, employees would be "considered fully

vaccinated for COVID-19 two weeks after [the employee] ha[d]

received the second dose in a two-dose series (Pfizer-BioNTech or

Moderna) or two weeks after they ha[d] received a single-dose

vaccine (Johnson and Johnson/Janssen)." Those who failed to

provide timely proof of vaccination were subject to termination

for cause.

The policy, however, provided a procedure by which

employees could request a religious exemption from the vaccination

- 3 - requirement. To do so, an employee needed to submit an

accommodation request form accompanied by "a written statement

describing [their] sincerely held religious belief, practice, or

observance and how it conflict[ed] with . . . receiving the

COVID-19 vaccination." Ipsen reviewed all such "requests on a

case-by-case basis."

Thornton, who at the time was employed by Ipsen as

Associate Director - Patient Safety, sought a religious exemption

from the vaccination requirement on October 26, 2021. In her

accommodation request form, she stated the following:

[B]eing a very private person, this process that requires me to divulge my sincerely held beliefs and personal medical information makes me extremely uncomfortable. Receiving a vaccine (including the [COVID-19] vaccine) goes against my personal, private and sincerely held religious beliefs. Therefore, I am requesting a reasonable accommodation based on my religious convictions. My long standing beliefs are sincerely held and firmly established in my faith, the Holy Bible and my awareness that what God has created is perfect.

On November 2, 2021, Ipsen denied Thornton's request.

Even though the vaccination policy did not provide for

an internal appeal process, Thornton still tried to appeal the

denial by submitting a letter to Ipsen on November 5, 2021.

Therein, she elaborated further:

I have never had to defend my faith and it is difficult for me to put into words my sincerely held religious beliefs that I hold

- 4 - in my heart and soul. I demonstrate my sincerely held religious beliefs not only in how I think, but in how I live my life every day. God requires me to follow His Word and His Teachings so that I may live in Grace and have eternal salvation. In practicing my faith, which requires me to keep my body and soul pure to God's standard as He created, I follow God's word by . . . [p]raying to God. . . . God does not make mistakes and I am created in His image and defying what He has created is a sin and morally wrong. . . . I have not received a vaccine in at least twenty years. Through much prayer and listening to the guidance of the Holy Spirit, it would violate my sincerely held religious beliefs and jeopardize my soul and eternal salvation to go against God by defiling my perfectly created body that He created in His image by receiving the vaccine. This is the way I choose to interpret God's Word; the messages I have received from God; and is my own personal translation of His teachings.

Ipsen made no decision regarding this letter, nor did Thornton

comply with the vaccination requirement. As a result, Ipsen

terminated Thornton's employment on November 10, 2021.

Six days later, Thornton filed a religious

discrimination charge with the Equal Employment Opportunity

Commission ("EEOC"), which is empowered to enforce Title VII. 42

U.S.C. § 2000e-5. The EEOC dismissed the charge and issued

Thornton a right-to-sue letter on August 30, 2022. Thornton then

filed in Massachusetts Superior Court a complaint against Ipsen,

which she twice amended. In her second amended complaint ("SAC"),

Thornton alleges the following three counts: (1) religious

discrimination in violation of Title VII and Chapter 151B;

- 5 - (2) violation of her equal protection rights under the Fourteenth

Amendment to the United States Constitution; and (3) violation of

her substantive and procedural due process rights under the

Fourteenth Amendment to the United States Constitution and the

MDR.

On May 25, 2023, Ipsen removed the case to the United

States District Court for the District of Massachusetts and, a

week later, moved to dismiss Thornton's SAC under Federal Rule of

Civil Procedure 12(b)(6). The parties then consented to having

the case referred to the U.S. Magistrate Judge for all further

proceedings, including entry of final judgment. See 28 U.S.C.

§ 636(c).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Untitled Case
D. Massachusetts, 2026
DeAngelis v. Hasbro, Inc.
First Circuit, 2026
Hewes v. Gardiner
First Circuit, 2025
SMALL v. SMITH
D. Maine, 2025
Teles De Menezes v. Rubio
First Circuit, 2025
Laurence, Jr. v. Nerohna
D. Rhode Island, 2025

Cite This Page — Counsel Stack

Bluebook (online)
126 F.4th 76, Counsel Stack Legal Research, https://law.counselstack.com/opinion/thornton-v-ipsen-biopharmaceuticals-inc-ca1-2025.